期刊文献+

老年痴呆症药物治疗进展 被引量:14

Development of Drug Therapy for Alzheimer’s Disease
暂未订购
导出
摘要 老年痴呆症是一种进行性记忆与认知丧失的疾病 ,目前尚无疗效满意的治疗药物。本文就老年痴呆症的对因治疗和对症治疗 ,延迟疾病恶化 。 Alzheimer's disease is characterized by progressive loss of memory and cognitive function. In this article,a number of theraputic drugs available or inclinical study for Alzheimer's disease, including acetylcholinesterase inhibitors, were introduced in the light of cause and symptom therapy.
出处 《药学进展》 CAS 2000年第6期338-341,共4页 Progress in Pharmaceutical Sciences
关键词 老年痴呆症 拟胆碱药治疗 认知功能 精神症状 Alzheimer’s disease Cholinomimetic therapy Cognitive function Psychopathic symptom
  • 相关文献

参考文献10

  • 1Frenchman IB,Prince T.Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances[].International Psychogeriatrics IPA.1997
  • 2Thal LJ,Ferguson JM,Mintzer J,et al.A 24-week randomized trial of controlled release physostigmine in patients with Alzheimer’s disease[].Neurology.1999
  • 3Imbimbo BP,Lucca U,Lucchelli F,et al.A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer’s disease[].Alzheimer Disease and Associated Disorders.1998
  • 4Burns A,Rossor M,Hecker J,et al.The effects of donepezil in Alzheimer’s disease- results from a multinational trial[].Dementia and Geriatric Cognitive Disorders.1999
  • 5Weyer G,Babej-Dolle RM,Hadler D,et al.A controlled study of two doses of idebenone in the treatment of Alzheimer’s disease[].Neuro- psychobiology.1997
  • 6Corey-Bloom J,Anand R,Veach J.A randomized trial evaluating the efficacy and safety of rivastigmine tartarate, a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease[].J Geriatr Psychopharmacol.1998
  • 7Oken BS,Storzbach DM,Kaye JA.The efficacy of Ginkgo biloba on cognitive function in Alzheimer’s disease[].Archives of Neurology.1998
  • 8McKhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease[].Neurology.1984
  • 9Cummings JL,Cyrus F,Bieber J,et al.Metrifonate treatment of the cognitive deficits of Alzheimer’s disease[].Neurology.1998
  • 10Bodick NC,Offen WW,Levey AI,et al.The effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer’s disease[].Archives of Neurology.1997

同被引文献145

引证文献14

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部